P24.01
Meconium aspiration with respiratory symptoms
Clinical Classification Guidelines
Use Additional Code
- code to identify any secondary pulmonary hypertension, if applicable (I27.2-)
Inclusion Terms
- Meconium aspiration pneumonia
- Meconium aspiration pneumonitis
- Meconium aspiration syndrome NOS
Medical Intelligence & Overview
Meconium Aspiration Syndrome (MAS) is a condition that affects newborns when they inhale a mixture of meconium and amniotic fluid into their lungs around the time of birth. Meconium is the first stool passed by a newborn, typically composed of intestinal cells, mucus, and other substances. When a fetus experiences stress during labor, it may release meconium into the amniotic fluid, increasing the risk of inhalation. MAS can cause respiratory difficulties in newborns and requires prompt medical attention to manage symptoms and prevent complications.
Causes & Symptoms
Clinical Causes: Fetal stress or distress during labor or delivery Post-term pregnancy (beyond 42 weeks gestation) Placental insufficiency reducing oxygen supply to the fetus Umbilical cord compression Intrauterine hypoxia leading to fetal gasping and inhalation of meconium Maternal infections or illnesses Certain genetic or prenatal factors that compromise fetal conditions
Key Symptoms: Rapid and labored breathing Grunting sounds during respiration Cyanosis, or bluish discoloration of the skin and lips Poor feeding or difficulty eating Respiratory distress that may worsen after birth Lung crackles or rales heard during examination Tachypnea, or an abnormally fast respiratory rate
Diagnostic & Treatment
Diagnosis Path: Diagnosis of Meconium Aspiration Syndrome involves a combination of clinical assessment and diagnostic tests, including: - Observation of respiratory distress signs soon after birth - Physical examination focusing on lung sounds and skin color - Chest X-rays to visualize meconium-stained lung fields and assess lung condition - Blood tests to evaluate oxygen and carbon dioxide levels - Blood gas analysis to determine the degree of respiratory compromise These assessments help differentiate MAS from other neonatal respiratory conditions and guide treatment planning.
Treatment Protocols: Treatment strategies for MAS focus on supportive care and minimizing lung inflammation. Approaches include: - Providing oxygen therapy, often through nasal cannula or mechanical ventilation, to maintain adequate oxygen levels - Extracorporeal membrane oxygenation (ECMO) in severe cases where other interventions are insufficient - Suctioning the airways to remove meconium from the mouth, nose, and trachea, - Administering medications such as antibiotics if infection is suspected - Using surfactant therapy to improve lung compliance and reduce surface tension - Monitoring respiratory status continuously to adjust care as needed - Managing complications like persistent pulmonary hypertension Effective management of MAS requires a multidisciplinary approach to support the newborn's breathing and address any associated issues, reducing the risk of long-term health problems.
Clinical Advice & FAQs
Billing Guidance
Is P24.01 a billable ICD-10 code?
Yes, P24.01 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report P24.01?
Clinical documentation must specify the nature of Meconium aspiration with respiratory symptoms and any associated comorbidities for accurate reporting.
Cite this Clinical Reference